Oramed Pharmaceuticals
0 sources
Financials
0001213900-26-034835Oramed Pharmaceuticals
Summary
Oramed Pharmaceuticals is a business[1].
Key Facts
- Oramed Pharmaceuticals is in the country of Israel[2].
- Oramed Pharmaceuticals is in the country of United States[3].
- Oramed Pharmaceuticals is in the country of US[4].
- Oramed Pharmaceuticals's instance of is recorded as business[5].
- Oramed Pharmaceuticals's instance of is recorded as enterprise[6].
- Oramed Pharmaceuticals's instance of is recorded as public company[7].
- Oramed Pharmaceuticals's headquarters location is recorded as Jerusalem[8].
- Oramed Pharmaceuticals's headquarters location is recorded as New York City[9].
- Oramed Pharmaceuticals's chief executive officer is recorded as Nadav Kidron[10].
- Oramed Pharmaceuticals's stock exchange is recorded as Nasdaq[11].
- Oramed Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
- 2006 marks the founding of Oramed Pharmaceuticals[13].
- Oramed Pharmaceuticals's official website is recorded as http://www.oramed.com[14].
- Oramed Pharmaceuticals's product or material produced is recorded as Oral Insulin[15].
- Oramed Pharmaceuticals's legal form is recorded as public company[16].
- Oramed Pharmaceuticals's legal form is recorded as 8888[17].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 5299006K52ZIIGQJ6R84[18]
-
Registered legal name: Oramed Pharmaceuticals Inc.[19]
-
Legal jurisdiction: US-DE[20]
-
GLEIF entity category: GENERAL[21]
-
Legal form (ISO 20275 ELF): 8888[22]
-
Other legal form: Corporation[23]
-
Entity status: ACTIVE[24]
-
LEI registration status: LAPSED[25]
-
LEI first registered: 2018-12-17[26]
-
LEI last updated: 2021-07-14[27]
-
LEI next renewal: 2019-12-17[28]
-
Managing LOU: 5299000J2N45DDNE4Y28[29]
-
Registration authority: RA000602[30]
-
Authority entity ID: 4951722[31]
-
Conformity flag: NON_CONFORMING[32]
Body
Founding
2006 marks the founding of Oramed Pharmaceuticals[13].
Leadership
Oramed Pharmaceuticals's chief executive officer is recorded as Nadav Kidron[10].
Operations
Headquarters locations include Jerusalem[8], a city[33], in Kingdom of Judah[34], founded in -4000[35] and New York City[9], a global city[36], in United States[37], founded in 1624[38].
Industry
Oramed Pharmaceuticals's industry is recorded as pharmaceutical industry[12].
Ownership
Oramed Pharmaceuticals's stock exchange is recorded as Nasdaq[11]. Its product or material produced is recorded as Oral Insulin[15].